Thank you for that question and for rekindling our hockey memories.
I think the federal government can make sure that public money is spent appropriately. In fact, in departments such as Health Canada, there is an increasing number of requirements and challenges. We must make sure that we are properly equipped to address needs and to understand the beneficial effects of drugs, etc., and by doing so, make sure that there are no delays. As well, other federal agencies such as the PMPRB, the Patented Medicine Prices Review Board, work well, and perhaps do not need to continue receiving the same investment amounts.
Allow me to answer your question in broad terms: this will depend on the decision-making process, licences, and notices of compliance. The government must be more strategic in how public money is spent. Then, as you rightly point out, it falls to the CDR, the Common Drug Review, and the provinces.
One other thing: we can insist that the government no longer allow artificial delays. We must put ourselves in the shoes of patients. Nobody wants to see delays in access to life-saving medicines.